We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.06%
5 Year Est. Return
+91.11%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.13% |
| 2 | Technology | 15.85% |
| 3 | Healthcare | 13.96% |
| 4 | Energy | 13.9% |
| 5 | Financials | 12.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
HubSpot
HUBS
$12.3B
| $52.7M | 0.07% |
317,021
-129
| -0% | -$20.4K |
|
302
CME Group
CME
$101B
| $52.7M | 0.07% |
319,967
-614,828
| -66% | -$109M |
|
303
Euronet Worldwide
EEFT
$2.76B
| $52.4M | 0.07% |
367,637
+55,737
| +18% | +$6.95M |
|
304
Roper Technologies
ROP
$40.3B
| $52.3M | 0.07% |
153,079
-3,537
| -2% | -$1.07M |
|
305
Novartis
NVS
$304B
| $52.2M | 0.06% |
605,768
-13,362
| -2% | -$1.07M |
|
306
DaVita
DVA
$11.7B
| $51.3M | 0.06% |
945,267
-146,026
| -13% | -$8.08M |
|
|
NLSN
307
DELISTED
Nielsen Holdings plc
NLSN
| $50.9M | 0.06% |
2,149,312
-1,453,715
| -40% | -$37.6M |
|
308
Comcast
CMCSA
$94B
| $50.8M | 0.06% |
1,270,291
+6,128
| +0.5% | +$231K |
|
309
Dolby
DLB
$5.8B
| $50.7M | 0.06% |
805,375
+2,657
| +0.3% | +$170K |
|
310
Starwood Property Trust
STWD
$5.95B
| $50.6M | 0.06% |
2,263,781
-38,320
| -2% | -$836K |
|
311
Ascendis Pharma A/S
ASND
$17.7B
| $50.2M | 0.06% |
426,318
-1,022
| -0.2% | -$89.5K |
|
312
IQVIA
IQV
$44.1B
| $50M | 0.06% |
347,738
+34,161
| +11% | +$4.55M |
|
313
NextEra Energy
NEE
$174B
| $49.6M | 0.06% |
1,025,812
-375,880
| -27% | -$17.2M |
|
314
Corpay
CPAY
$27.3B
| $49.5M | 0.06% |
200,884
-1,371
| -0.7% | -$297K |
|
|
MTLS
315
Materialise
MTLS
$432M
| $48.9M | 0.06% |
3,105,877
+886,455
| +40% | +$15.6M |
|
|
COUP
316
DELISTED
Coupa Software Incorporated
COUP
| $48.9M | 0.06% |
537,230
+64,856
| +14% | +$5.56M |
|
317
CACI
CACI
$13.8B
| $48.5M | 0.06% |
266,682
+5,884
| +2% | +$1M |
|
318
Hexcel
HXL
$6.96B
| $48.4M | 0.06% |
700,175
-2,922
| -0.4% | -$196K |
|
|
AGN
319
DELISTED
Allergan plc
AGN
| $48.1M | 0.06% |
328,855
-19,194
| -6% | -$2.78M |
|
320
FirstEnergy
FE
$27.1B
| $47.3M | 0.06% |
1,136,844
-48,491
| -4% | -$1.93M |
|
|
WMGI
321
DELISTED
Wright Medical Group Inc
WMGI
| $47.2M | 0.06% |
1,500,702
+886,324
| +144% | +$26.9M |
|
|
WCG
322
DELISTED
Wellcare Health Plans, Inc.
WCG
| $46.9M | 0.06% |
173,692
-208,626
| -55% | -$53.9M |
|
323
MongoDB
MDB
$29.7B
| $46.8M | 0.06% |
318,370
-45,210
| -12% | -$4.64M |
|
324
Penumbra
PEN
$12.7B
| $46.7M | 0.06% |
317,484
+34,033
| +12% | +$4.86M |
|
|
SEE
325
DELISTED
Sealed Air
SEE
| $46.5M | 0.06% |
1,008,848
-17,408
| -2% | -$723K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.